Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation
Ataxia-telangiectasia mutated (ATM), a master kinase of the DNA damage response (DDR), phosphorylates a multitude of substrates to activate signaling pathways after DNA double-strand breaks (DSBs). ATM inhibitors have been evaluated as anticancer drugs to potentiate the cytotoxicity of DNA damage-based cancer therapy. ATM is also involved in autophagy, a conserved cellular process that maintains homeostasis by degrading unnecessary proteins and dysfunctional organelles. In this study, we report that ATM inhibitors (KU-55933 and KU-60019) provoked accumulation of autophagosomes and p62 and restrained autolysosome formation. Under autophagy-inducing conditions, the ATM inhibitors caused excessive autophagosome accumulation and cell death. This new function of ATM in autophagy was also observed in numerous cell lines. Repression of ATM expression using an siRNA inhibited autophagic flux at the autolysosome formation step and induced cell death under autophagy-inducing conditions. Taken together, our results suggest that ATM is involved in autolysosome formation and that the use of ATM inhibitors in cancer therapy may be expanded.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Biomolecules & therapeutics - 31(2023), 5 vom: 01. Sept., Seite 559-565 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hwang, Mihwa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ATM |
|---|
| Anmerkungen: |
Date Revised 02.09.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4062/biomolther.2023.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354464426 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354464426 | ||
| 003 | DE-627 | ||
| 005 | 20231226062258.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4062/biomolther.2023.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1181.xml |
| 035 | |a (DE-627)NLM354464426 | ||
| 035 | |a (NLM)36941082 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hwang, Mihwa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 02.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Ataxia-telangiectasia mutated (ATM), a master kinase of the DNA damage response (DDR), phosphorylates a multitude of substrates to activate signaling pathways after DNA double-strand breaks (DSBs). ATM inhibitors have been evaluated as anticancer drugs to potentiate the cytotoxicity of DNA damage-based cancer therapy. ATM is also involved in autophagy, a conserved cellular process that maintains homeostasis by degrading unnecessary proteins and dysfunctional organelles. In this study, we report that ATM inhibitors (KU-55933 and KU-60019) provoked accumulation of autophagosomes and p62 and restrained autolysosome formation. Under autophagy-inducing conditions, the ATM inhibitors caused excessive autophagosome accumulation and cell death. This new function of ATM in autophagy was also observed in numerous cell lines. Repression of ATM expression using an siRNA inhibited autophagic flux at the autolysosome formation step and induced cell death under autophagy-inducing conditions. Taken together, our results suggest that ATM is involved in autolysosome formation and that the use of ATM inhibitors in cancer therapy may be expanded | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ATM | |
| 650 | 4 | |a Autolysosome | |
| 650 | 4 | |a Autophagy | |
| 650 | 4 | |a Cancer therapy | |
| 650 | 4 | |a Combination therapy | |
| 700 | 1 | |a Jun, Dong Wha |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Bo Ram |e verfasserin |4 aut | |
| 700 | 1 | |a Shim, Hanna |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Chang-Hun |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Sunshin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomolecules & therapeutics |d 2010 |g 31(2023), 5 vom: 01. Sept., Seite 559-565 |w (DE-627)NLM203577426 |x 1976-9148 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2023 |g number:5 |g day:01 |g month:09 |g pages:559-565 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4062/biomolther.2023.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2023 |e 5 |b 01 |c 09 |h 559-565 | ||